6730 Stock Overview
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Lagis Enterprise Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$40.50 |
| 52 Week High | NT$50.20 |
| 52 Week Low | NT$36.25 |
| Beta | -0.014 |
| 1 Month Change | -10.00% |
| 3 Month Change | 7.14% |
| 1 Year Change | -1.10% |
| 3 Year Change | 1.38% |
| 5 Year Change | n/a |
| Change since IPO | -44.92% |
Recent News & Updates
Recent updates
Be Wary Of Lagis Enterprise (GTSM:6730) And Its Returns On Capital
Mar 23
Are Lagis Enterprise Co., Ltd.'s (GTSM:6730) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Jan 20
Factors Income Investors Should Consider Before Adding Lagis Enterprise Co., Ltd. (GTSM:6730) To Their Portfolio
Dec 14Shareholder Returns
| 6730 | TW Medical Equipment | TW Market | |
|---|---|---|---|
| 7D | -1.3% | 1.6% | -2.3% |
| 1Y | -1.1% | 7.0% | 27.2% |
Return vs Industry: 6730 underperformed the TW Medical Equipment industry which returned 7% over the past year.
Return vs Market: 6730 underperformed the TW Market which returned 27.2% over the past year.
Price Volatility
| 6730 volatility | |
|---|---|
| 6730 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 6730 has not had significant price volatility in the past 3 months.
Volatility Over Time: 6730's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | n/a | www.lagis.com.tw |
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and related accessories. The company was founded in 1993 and is headquartered in Taichung, Taiwan.
Lagis Enterprise Co., Ltd. Fundamentals Summary
| 6730 fundamental statistics | |
|---|---|
| Market cap | NT$1.30b |
| Earnings (TTM) | NT$46.43m |
| Revenue (TTM) | NT$400.52m |
27.9x
P/E Ratio3.2x
P/S RatioIs 6730 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6730 income statement (TTM) | |
|---|---|
| Revenue | NT$400.52m |
| Cost of Revenue | NT$202.62m |
| Gross Profit | NT$197.91m |
| Other Expenses | NT$151.47m |
| Earnings | NT$46.43m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.45 |
| Gross Margin | 49.41% |
| Net Profit Margin | 11.59% |
| Debt/Equity Ratio | 6.1% |
How did 6730 perform over the long term?
See historical performance and comparison